Search results for: 'pack point analysis for laboratory develop'

Management of infectious diseases remains a critical challenge for public health professionals who face increasing demand to control the spread of existing and novel diseases. To provide appropriate healthcare assistance, it is imperative to diagnose the exact form of infection from an array of complicated symptoms expressed by the host. As the out...

Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...

Frost & Sullivan conducts an annual survey of IT and business decision-makers regarding their views of different technologies, such as immersive services, the metaverse, the Internet of Things, artificial intelligence, and the cloud. This report leverages the information collected on Frost & Sullivan s 2023 IT Decision Makers Survey to analyze t...

08 Oct 2021  |  North America  |  Market Research

Global Tissue Diagnostics (TDx) Growth Opportunities

Companion Diagnostics (CDx)-specific Advanced Staining and Anatomical Pathology Laboratory Information Systems (APLIS) to Drive Ma

Infographics

×

This research service provides an overview of the global TDx market and a 4-year forecast of it from 2021 to 2025. The market will reach $8,848.6 million in 2025, growing at a compound annual growth rate (CAGR) of 8.9% from 2020 to 2025. The advanced staining and anatomical pathology laboratory information management systems (APLIS) segments will g...

The Transformational Health team at Frost & Sullivan provides critical insights into the US and EU laboratory information management system (LIMS) industry, highlighting the key growth opportunities, market revenue forecast, and trends that will play an important role in industry growth. The US and EU LIMS market covered in this study is segmented...

17 Jun 2021  |  North America  |  Market Research

Global Biologics Contract Development and Manufacturing Organizations Growth Opportunities

Asset Co-Development with Clinical-stage Biopharmaceutical Companies and Disruptive Technologies Present Future Growth Potential

Infographics

×

This study presents Frost & Sullivans overall market and segment-wise revenue forecasts of the global biologics contract development and manufacturing organizations (bio-CDMO) market. It also highlights key growth opportunities for bio-CDMO market participants based on the main evolution in their business models and strategic approaches, as well as...

This study covers the state of the global marine and algae oil EPA/DHA Omega-3 ingredient market, examining drivers and restraints for growth, pricing, distribution, technology, legislation, demand and geographical trends. Following from these, market growth for market segments are forecasted. In addition, an in-depth analysis of the competitive si...

The U.S. Point-of-Care Retail Diagnostic report focuses on the largest segments of this market, pregnancy and ovulation. This report includes revenues and market share information, as well as a forecast to 2009, using 2002 as the base year. The study includes detailed analysis of market trends, challenges, drivers, strategies, pricing and demand....

The objective of this research is to analyze the growth potential of telematics-enabled usage-based insurance (UBI) service in the North American market. The study also illustrates the impact of legislations put forth in California on the total telematics-enabled UBI market. The main objective of this study is to highlight the following: The market...